Alejo Parellada
Addiction Medicine · Brooklyn, NYNPI 1417070442
Payments from drug & device makers
Across 861 payments — averaging $25.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Otsuka America Pharmaceutical, Inc.$5K
- Alkermes, Inc.$3K
- Teva Pharmaceuticals USA, Inc.$2K
- Lundbeck LLC$2K
- E.r. Squibb & Sons, L.L.C.$1K
- plus $4K from 16 others
What the payments were for
- Food & beverage$21,71199%
- Education$2931%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 297 | $4,966 |
| Otsuka America Pharmaceutical, Inc. | 127 | $4,550 |
| Alkermes, Inc. | 137 | $3,459 |
| Teva Pharmaceuticals USA, Inc. | 62 | $2,473 |
| Lundbeck LLC | 83 | $1,604 |
| E.r. Squibb & Sons, L.L.C. | 19 | $1,111 |
| Johnson & Johnson | 13 | $540 |
| Idorsia Pharmaceuticals US Inc | 20 | $539 |
| Axsome Therapeutics, Inc. | 13 | $516 |
| Orexo US, Inc. | 29 | $464 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $408 |
| Vanda Pharmaceuticals Inc. | 12 | $369 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $203 |
| Indivior Inc. | 9 | $187 |
| Gilead | 3 | $183 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $143 |
| Braeburn Inc. | 4 | $106 |
| MDD US Operations, LLC | 6 | $93 |
| Noven Pharmaceuticals, Inc. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
| USWM, LLC | 1 | $18 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,004 in reported general payments places this provider in the 90th percentile of 125 addiction medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 47 | $109,232 |
| VivitrolNaltrexone Microspheres | 36 | $55,322 |
| RexultiBrexpiprazole | 27 | $37,654 |
| AristadaAripiprazole Lauroxil | 12 | $34,697 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 142 | $22,125 |
| Clonazepam | 304 | $1,943 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 63 | $1,543 |
| Aripiprazole | 54 | $1,525 |
| Quetiapine Fumarate | 104 | $1,243 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 28 | $1,126 |
| Alprazolam | 180 | $917 |
| Bupropion XlBupropion Hcl | 68 | $863 |
| Gabapentin | 85 | $688 |
| Mirtazapine | 72 | $618 |
| Ziprasidone Hcl | 11 | $602 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $4,550 | $146,88674 claims |
| Alkermes, Inc.Vivitrol, Aristada | $3,459 | $90,01948 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 125 addiction medicine providers in New York.
Other addiction medicine in Brooklyn
- Oskar VarshavskiyBrooklyn$7K
- Lynda Smith HarrisBrooklyn$7K
- Jacquelin BelamyBrooklyn$778
- Alain LitwinBronx$1.8M
- Joshua LeeNew York$1.1M
- Julia ArnstenBronx$292K
- Edmond HakimiCalverton$125K
- Dawn HarbatkinAmherst$111K
- James WolbergNew York$45K
- Mohammed IsmailTroy$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.